More News

28 Oct 2020 insitro Announces Five-Year Discovery Collaboration with Bristol Myers Squibb to Discover and Develop Novel Treatments for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
26 Oct 2020 AnaptysBio and GlaxoSmithKline Amend Strategic Immuno-Oncology Collaboration
23 Oct 2020 Arixa Pharmaceuticals Announces Acquisition by Pfizer’s Hospital Business
23 Oct 2020 Retrophin Announces Agreement to Acquire Orphan Technologies
19 Oct 2020 Genesis Therapeutics Enters AI-driven, Multi-Target Drug Discovery Partnership with Genentech
19 Oct 2020 Endo to Acquire BioSpecifics to Enhance Profitability of XIAFLEX® and Qwo™
17 Oct 2020 Denali Therapeutics to Highlight Progress Across Broad Biotherapeutics Portfolio for Neurodegeneration Enabled by Its Blood-Brain Barrier (BBB) TV Platform at Virtual R&D Day Today
16 Oct 2020 XL-protein and Antlia Bioscience Announce Collaboration to Develop Long-acting Peptide Therapy of Chronic Heart Failure using PASylation Technology
15 Oct 2020 Lilly Announces Agreement to Acquire Disarm Therapeutics
14 Oct 2020 Boehringer Ingelheim and Oxford BioTherapeutics Expand Collaboration to Discover Novel Selective Tumor Targets as First Bispecific Antibody Advanced into the Clinic
14 Oct 2020 Dyno Therapeutics Enters Collaboration and License Agreement with Roche to Develop Next-Generation AAV Gene Therapy Vectors for CNS Diseases and Liver-Directed Therapies
14 Oct 2020 Secarna Pharmaceuticals and Denali Therapeutics Enter Into Research and Option Agreement to Develop Novel Antisense Therapies in the Field of Neurodegenerative Diseases
13 Oct 2020 Twist Bioscience and Neogene Announce Broad Strategic Partnership for Next Generation Personalized T Cell Therapies
12 Oct 2020 HitGen to Acquire Vernalis, a Leader in Structure-Based Drug Discovery
08 Oct 2020 The University of Tokyo and Eisai Announce Research Collaboration for the Development and Drug Discovery of Targeted Protein Degradation Technology
07 Oct 2020 Forbion Portfolio Company, Enterprise Therapeutics’ First-in-Class TMEM16A Potentiator Program for Treatment of Cystic Fibrosis and Other Respiratory Diseases Acquired by Roche
06 Oct 2020 Scribe Therapeutics to Collaborate With Biogen to Develop CRISPR-based Genetic Medicines for Neurological Diseases, Including Amyotrophic Lateral Sclerosis
06 Oct 2020 Chugai Enters into a License Agreement for Chugai’s Antibody Engineering Technologies with argenx
06 Oct 2020 BridgeBio Pharma and Eidos Therapeutics Announce Merger Agreement
06 Oct 2020 Mustang Bio Licenses LentiBOOST™ Technology from SIRION Biotech
06 Oct 2020 Nimble Announces Strategic Research Collaboration with Incyte to Discover Novel Peptide-Based Therapeutics
06 Oct 2020 Bristol Myers Squibb to Acquire MyoKardia for $13.1 Billion in Cash
02 Oct 2020 Covis Group Announces Agreement to Acquire AMAG Pharmaceuticals
30 Sep 2020 CStone, Pfizer Enter into Strategic Collaboration to Address Oncological Needs in China
21 Sep 2020 Bausch Health To Acquire Option To Purchase All Ophthalmology Assets Of Allegro Ophthalmics

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top